Stage IV/Metastatic Breast Cancer, Open to All To Contribute
Discussion List
-
Most W/ MBC Have Troubling SEs, Willing To Discuss Dosing
Most Women With Metastatic Breast Cancer Have Troubling Treatment Side Effects, Willing To Discuss Dosing Options With Doctor June 16, 2021 About 86% of women diagnosed with metastatic breast cancer had at least one bad treatment-related side effect, and 92% were willing to discuss options for different dosing levels of…
-
Who has been diagnosed with bone, liver, and lung Metz
today my onc told me after the ct scan that I have bone, liver, lung Mets. They will look at PET scan soon. Did any of you have all 3. What are my chances. Onc told me in last years they have so many more options They will do a liver biopsy on Thursday. Not sure why the liver. I was shocked about the lung, Can I get to NED…
-
Complementary Treatment and Self Care For Stage IV & Others
I have thought about starting this thread and see if others want to participate so today, I am finally getting around to it. Feel free to share anything you are doing to help yourself feel better, deal with side effects, keep your strength up, improve emotional well being, etc. I'll start by sharing a video on…
-
Tukysa + Standard Tx Improves Survival in Advanced HER2+
Adding Tukysa to Standard of Care Continues To Improve Survival in Advanced-Stage HER2-Positive Breast Cancer June 15, 2021 Adding Tukysa to the standard of care of Herceptin and Xeloda continued to improve both progression-free and overall survival in people diagnosed with either metastatic or unresectable locally…
-
Kisqali-Faslodex Combo Improves Overall Survival in Advanced HR+
Kisqali-Faslodex Combo Continues To Improve Overall Survival in Advanced-Stage, Hormone-Receptor-Positive Breast Cancer in Postmenopausal Women June 20, 2021 The latest results from the MONALEESA-3 study show that combining Kisqali plus Faslodex continues to offer better overall survival than Faslodex alone. Read more...
-
Ibrance-Faslodex Combo Improves Overall Survival in Advanced HR+
Ibrance-Faslodex Combo Continues To Improve Overall Survival in Advanced-Stage, Hormone-Receptor-Positive Breast Cancer June 10, 2021 The latest results from the PALOMA-3 trial show that combining Ibrance and Faslodex continues to offer better overall survival than Faslodex alone. Read more...
-
My sister got the talk yesterday I’m crushed
my sister was diagnosed 2016 Mets to bone. last fall it was discovered in her liver. Her last treatment was a trial ibrance2 she didn't handle it well. Her platelets are low and they don't feel like she can undergo any additional treatments because of the progression in liver yesterday we got the news they are moving to…